Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Adler, LE; Olincy, A; Cawthra, E; Hoffer, M; Nagamoto, HT; Amass, L; Freedman, R
   Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism
   NEUROPSYCHOPHARMACOLOGY
   
   L.E. Adler et al., "Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism", NEUROPSYCH, 24(6), 2001, pp. 671-679
2. Amass, L; Kamien, JB; Mikulich, SK
   Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans
   DRUG AND ALCOHOL DEPENDENCE
   
   L. Amass et al., "Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans", DRUG AL DEP, 61(2), 2001, pp. 173-181
3. Amass, L; Kamien, JB; Mikulich, SK
   Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet
   DRUG AND ALCOHOL DEPENDENCE
   
   L. Amass et al., "Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet", DRUG AL DEP, 58(1-2), 2000, pp. 143-152
4. Stanger, C; Higgins, ST; Bickel, WK; Elk, R; Grabowski, J; Schmitz, J; Amass, L; Kirby, KC; Seracini, AM
   Behavioral and emotional problems among children of cocaine- and opiate-dependent parents
   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
   
   C. Stanger et al., "Behavioral and emotional problems among children of cocaine- and opiate-dependent parents", J AM A CHIL, 38(4), 1999, pp. 421-428
5. Bickel, WK; Amass, L; Crean, JP; Badger, GJ
   Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients
   PSYCHOPHARMACOLOGY
   
   W.K. Bickel et al., "Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients", PSYCHOPHAR, 146(2), 1999, pp. 111-118
6. BUDNEY AJ; BICKEL WK; AMASS L
   MARIJUANA USE AND TREATMENT OUTCOME AMONG OPIOID-DEPENDENT PATIENTS
   Addiction
   
   A.J. Budney et al., "MARIJUANA USE AND TREATMENT OUTCOME AMONG OPIOID-DEPENDENT PATIENTS", Addiction, 93(4), 1998, pp. 493-503
7. AMASS L; BICKEL WK; CREAN JP; BLAKE J; HIGGINS ST
   ALTERNATE-DAY BUPRENORPHINE DOSING IS PREFERRED TO DAILY DOSING BY OPIOID-DEPENDENT HUMANS
   Psychopharmacology
   
   L. Amass et al., "ALTERNATE-DAY BUPRENORPHINE DOSING IS PREFERRED TO DAILY DOSING BY OPIOID-DEPENDENT HUMANS", Psychopharmacology, 136(3), 1998, pp. 217-225
8. MOODY DE; LAYCOCK JD; SPANBAUER AC; CROUCH DJ; FOLTZ RL; JOSEPHS JL; AMASS L; BICKEL WK
   DETERMINATION OF BUPRENORPHINE IN HUMAN PLASMA BY GAS-CHROMATOGRAPHY POSITIVE-ION CHEMICAL-IONIZATION MASS-SPECTROMETRY AND LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY
   Journal of analytical toxicology
   
   D.E. Moody et al., "DETERMINATION OF BUPRENORPHINE IN HUMAN PLASMA BY GAS-CHROMATOGRAPHY POSITIVE-ION CHEMICAL-IONIZATION MASS-SPECTROMETRY AND LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY", Journal of analytical toxicology, 21(6), 1997, pp. 406-414
9. BICKEL WK; AMASS L; HIGGINS ST; BADGER GJ; ESCH RA
   EFFECTS OF ADDING BEHAVIORAL TREATMENT TO OPIOID DETOXIFICATION WITH BUPRENORPHINE
   Journal of consulting and clinical psychology
   
   W.K. Bickel et al., "EFFECTS OF ADDING BEHAVIORAL TREATMENT TO OPIOID DETOXIFICATION WITH BUPRENORPHINE", Journal of consulting and clinical psychology, 65(5), 1997, pp. 803-810
10. AMASS L; BICKEL WK; CREAN JP; HIGGINS ST; BADGER GJ
    PREFERENCES FOR CLINIC PRIVILEGES, RETAIL ITEMS AND SOCIAL ACTIVITIESIN AN OUTPATIENT BUPRENORPHINE TREATMENT PROGRAM
    Journal of substance abuse treatment
    
    L. Amass et al., "PREFERENCES FOR CLINIC PRIVILEGES, RETAIL ITEMS AND SOCIAL ACTIVITIESIN AN OUTPATIENT BUPRENORPHINE TREATMENT PROGRAM", Journal of substance abuse treatment, 13(1), 1996, pp. 43-49
11. AMASS L; BICKEL WK; HIGGINS ST; HUGHES JR
    A PRELIMINARY INVESTIGATION OF OUTCOME FOLLOWING GRADUAL OR RAPID BUPRENORPHINE DETOXIFICATION
    Journal of addictive diseases
    
    L. Amass et al., "A PRELIMINARY INVESTIGATION OF OUTCOME FOLLOWING GRADUAL OR RAPID BUPRENORPHINE DETOXIFICATION", Journal of addictive diseases, 13(3), 1994, pp. 33-45
12. AMASS L; BICKEL WK; HIGGINS ST; BADGER GJ
    ALTERNATE-DAY DOSING DURING BUPRENORPHINE TREATMENT OF OPIOID DEPENDENCE
    Life sciences
    
    L. Amass et al., "ALTERNATE-DAY DOSING DURING BUPRENORPHINE TREATMENT OF OPIOID DEPENDENCE", Life sciences, 54(17), 1994, pp. 1215-1228
13. BICKEL WK; AMASS L
    THE RELATIONSHIP OF MEAN DAILY BLOOD-ALCOHOL LEVELS TO ADMISSION MAST, CLINIC ABSENTEEISM AND DEPRESSION IN ALCOHOLIC METHADONE PATIENTS
    Drug and alcohol dependence
    
    W.K. Bickel e L. Amass, "THE RELATIONSHIP OF MEAN DAILY BLOOD-ALCOHOL LEVELS TO ADMISSION MAST, CLINIC ABSENTEEISM AND DEPRESSION IN ALCOHOLIC METHADONE PATIENTS", Drug and alcohol dependence, 32(2), 1993, pp. 113-118
14. AMASS L; BICKEL WK; HIGGINS ST; BUDNEY AJ; FOERG FE
    THE TAKING OF FREE CONDOMS IN A DRUG-ABUSE TREATMENT CLINIC - THE EFFECTS OF LOCATION AND POSTERS
    American journal of public health
    
    L. Amass et al., "THE TAKING OF FREE CONDOMS IN A DRUG-ABUSE TREATMENT CLINIC - THE EFFECTS OF LOCATION AND POSTERS", American journal of public health, 83(10), 1993, pp. 1466-1468